Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥202.8B | ¥188.9B | +7.4% |
| Operating Income | ¥3.9B | ¥5.0B | −21.3% |
| Ordinary Income | ¥5.5B | ¥6.4B | −13.7% |
| Net Income | ¥3.7B | ¥4.4B | −16.5% |
| ROE | 3.9% | 4.9% | - |
Executive Summary
The cumulative results for FY2026 Q3 showed higher revenue but lower earnings due to deteriorating profitability in the core business. Revenue increased to ¥202.8B (+7.4% YoY), while Operating Income declined to ¥3.9B (-21.3% YoY), Ordinary Income to ¥5.5B (-13.7% YoY), and Net Income to ¥3.7B (-16.5% YoY). In the core Chemicals Business, higher revenue coexisted with lower profit, and the decline in the gross profit margin affected the overall earnings structure.
Factors Affecting Performance
【Revenue】Revenue increased 7.4% YoY to ¥202.8B. By segment, the Chemicals Business led growth with revenue of ¥187.3B (92.4% of total, +9.1% YoY), while the Daily Necessities Business declined to ¥5.8B (-10.9% YoY) and the Civil Engineering and Construction Materials Business declined to ¥9.7B (-9.3% YoY).
【Profit and Loss】Although revenue increased, the gross profit margin remained low at 8.1%, while SG&A expenses increased to ¥12.5B (SG&A ratio: 6.2%). As a result, Operating Income declined to ¥3.9B (-21.3% YoY). By segment, Operating Income in the Chemicals Business decreased 8.7% from ¥5.2B to ¥4.8B, the Daily Necessities Business also declined 38.5%, and the Civil Engineering and Construction Materials Business swung from profit of ¥0.19B to a loss of ¥0.03B. Supported by non-operating income of ¥1.7B (dividend income of ¥1.0B and foreign exchange gains of ¥0.3B), Ordinary Income reached ¥5.5B, although this represented a decline of -13.7% YoY. Net Income was ¥3.7B (-16.5% YoY). The results comprised higher revenue but lower earnings: revenue growth was driven by the expansion of transaction volume in the Chemicals Business, but deteriorating profitability and higher company-wide expenses more than offset profit growth.
Segment Analysis
The Chemicals Business recorded revenue of ¥187.3B (+9.1% YoY) and Operating Income of ¥4.8B (-8.7% YoY), with its Operating Income margin narrowing from 2.8% to 2.5%. It accounts for the core of the Company in both revenue and profit, representing approximately 91% of total segment profit of ¥5.2B. The Daily Necessities Business recorded revenue of ¥5.8B (-10.9% YoY) and Operating Income of ¥0.48B (-38.5% YoY), with its profit margin also declining from 12.0% to 8.3%. The Civil Engineering and Construction Materials Business recorded revenue of ¥9.7B (-9.3% YoY) and an Operating Loss of ¥0.03B, turning into the red from the previous year's Operating Income of ¥0.19B. Company-wide expenses were ¥1.3B, up from ¥1.2B in the previous year, weighing on consolidated Operating Income. Profitability deteriorated across all three businesses, indicating a structural decline in earnings potential.
Key Financial Indicators
【Profitability】The Operating Income margin of 1.9% and Net Income margin of 1.8% both deteriorated from the previous year, while the gross profit margin of 8.1% represents a fundamental constraint arising from the Company's low-margin structure. 【Cash Flow Quality】Operating Cash Flow (OCF) is not included in the disclosed data; however, the expansion of working capital, comprising accounts receivable and notes receivable of ¥76.0B together with electronically recorded monetary claims, is a notable feature. DSO is approximately 103 days on an annualized basis, indicating a risk of funds being tied up during periods of revenue growth. 【Investment Efficiency】ROE was 3.9%. Under the DuPont decomposition, it was calculated as Net Income margin of 1.8% × total asset turnover of 1.053x × financial leverage of 2.07x, with the low profit margin representing the greatest constraint. 【Financial Soundness】The Equity Ratio was 48.2%, the current ratio was 153.6%, and the quick ratio was 146.3%, indicating sound short-term liquidity. The debt-to-equity ratio was 1.07x, and interest coverage was also extremely high, indicating limited financial risk.
Cash Flow Analysis
As actual values from the statement of cash flows are not included in the disclosed data, cash trends are analyzed based on changes in the balance sheet. Cash and deposits increased to ¥20.5B from ¥19.1B in the previous year, while accounts receivable and notes receivable expanded to ¥76.0B (¥64.6B in the previous year), indicating an expansion of working capital accompanying revenue growth. Accounts payable and notes payable also increased to ¥70.8B (¥50.1B in the previous year), indicating that funding on the procurement side expanded simultaneously. Investment securities remained broadly flat at ¥57.5B (¥55.8B in the previous year), with no major asset replacement observed. The fact that the pace of increase in accounts receivable is outstripping profit growth should be noted as a structural factor that could constrain cash generation from operating activities.
Earnings Quality
Of Ordinary Income of ¥5.5B, non-operating income was ¥1.7B, equivalent to approximately 43% of Operating Income of ¥3.9B. Its components were dividend income of ¥1.0B, foreign exchange gains of ¥0.3B, and other income of ¥0.2B, all of which are revenue sources independent of the core business. While Operating Income from the core business declined -21.3% YoY, these non-operating income items supported Ordinary Income. In terms of earnings quality, the Company's relative dependence on income from investment securities and foreign exchange factors has increased compared with improvement in the profitability of the core business. Comprehensive Income was ¥4.5B, exceeding Net Income attributable to owners of the parent of ¥3.7B, owing to a ¥1.0B increase in valuation difference on securities. This divergence is subject to market fluctuations and should be considered separately from the Company's realized earnings power for the current period.
Earnings Forecasts and Guidance
The full-year forecasts are revenue of ¥244.6B (-2.2% YoY), Operating Income of ¥4.05B (-27.5% YoY), Ordinary Income of ¥5.9B (-21.5% YoY), and Net Income of ¥4.17B. The cumulative Q3 progress rates were 82.9% for revenue, 96.7% for Operating Income, 92.6% for Ordinary Income, and 87.5% for Net Income. Operating Income and Ordinary Income are progressing ahead of the standard pace (approximately 75% after 9 cumulative months). However, against the full-year Operating Income forecast of ¥4.05B, cumulative actual Operating Income has already reached ¥3.9B, leaving limited scope for additional profit in Q4. Given that the full-year forecast itself anticipates lower revenue and earnings YoY, profitability trends in the second half will be key to achieving the plan.
Shareholder Returns
The full-year forecast indicates a dividend of ¥39 per share, implying a Payout Ratio of approximately 31.9% based on forecast EPS of ¥122.08. This Payout Ratio is below 60% on a Net Income basis and can be regarded as conservative relative to forecast earnings. Meanwhile, the Q2 dividend was ¥0, indicating a policy of concentrating the annual dividend in the year-end payment. As actual OCF is not included in the disclosed data, cash coverage of the dividend cannot be assessed; however, cash and deposits of ¥20.5B indicate a certain level of capacity to fund dividends.
Risk Factors
-
Deteriorating profitability in the Chemicals Business: Although revenue in the core Chemicals Business increased 9.1%, Operating Income declined 8.7%, and the Operating Income margin narrowed from 2.8% to 2.5%. Changes in procurement prices and transaction mix may be placing pressure on profitability.
-
The Civil Engineering and Construction Materials Business turning loss-making: The business swung from Operating Income of ¥0.19B in the same period of the previous year to an Operating Loss of ¥0.03B. Revenue also declined 9.3%, and demand trends and fluctuations in construction-related activity will be factors affecting future performance.
-
Prolonged collection of accounts receivable: Accounts receivable and notes receivable reached ¥76.0B, and annualized DSO is approximately 103 days. The expansion of working capital accompanying revenue growth should be noted as a risk that could constrain cash generation from operating activities.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (trading)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income margin | 1.9% | 3.3% (1.8%–5.0%) | −1.4pt |
| Net Income margin | 1.8% | 3.1% (1.4%–6.3%) | −1.3pt |
The Company's profitability metrics are below the industry median, positioning it as a low-margin company even within the wholesale industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (YoY) | 7.4% | 5.2% (-4.1%–8.6%) | +2.2pt |
The Company's revenue growth rate exceeds the industry median, indicating a relatively strong position in top-line growth.
※Source: Compiled by the Company
Key Points from the Financial Results
-
The progress rates against the full-year forecasts are favorable, at 96.7% for Operating Income and 87.5% for Net Income. However, these progress rates are measured against a conservative full-year plan that anticipates lower revenue and earnings YoY and do not indicate an improvement in underlying earnings power.
-
The coexistence of revenue growth and profit decline in the core Chemicals Business indicates a structure in which simple revenue growth does not directly translate into profit improvement. Trends in the gross profit margin and segment profitability will therefore be key areas of focus.
-
The structure in which non-operating income (dividend income and foreign exchange gains) supports Ordinary Income continues, confirming that income from investment securities of ¥57.5B is supplementing the earnings power of the core business.
This report is an earnings analysis document automatically generated by AI through analysis of XBRL financial results summary data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional adviser as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was mixed: revenue growth remained solid, but gross-margin compression and higher overhead reduced operating and net profit. Cumulative Q3 revenue increased 7.4% YoY to ¥202.79bn. Operating income declined 21.3% YoY to ¥3.91bn, despite the higher sales base. Ordinary income fell 13.7% to ¥5.50bn, while net income decreased 16.5% to ¥3.65bn. Gross profit rose only 1.9% to ¥16.41bn, materially lagging revenue growth. Consequently, the gross margin contracted by 43bp YoY to 8.1% from approximately 8.5%. SG&A expenses increased 12.2% YoY to ¥12.50bn, exceeding revenue growth and creating negative operating leverage. The operating margin fell by 72bp YoY to 1.9% from approximately 2.6%. Net profit margin declined by 50bp YoY to 1.8%. Non-operating income of ¥1.67bn supported ordinary profit, with dividend income of ¥0.95bn, foreign-exchange gains of ¥0.28bn, and interest income of ¥0.09bn being the principal contributors. This support partly cushioned the operating-profit decline, but it does not offset the underlying weakness in the operating margin. The annualized DuPont ROE was 5.2%, below the 8% level generally associated with adequate capital efficiency. Annualized ROIC of 4.8% also indicates that returns on the company’s capital base remain below the 5% warning threshold. The balance sheet retains adequate near-term liquidity, with a 153.6% current ratio and a 146.3% quick ratio. However, the ¥20.69bn YoY increase in trade payables materially funded working capital and merits monitoring alongside elevated receivable days of 103 days. FY2026 guidance appears conservative relative to Q3 cumulative results: revenue progress is 82.9%, operating-income progress is 96.7%, ordinary-income progress is 92.6%, and net-income progress is 87.6%, versus a standard 75% Q3 progress rate. The implied Q4 operating-income contribution is only ¥0.14bn, suggesting either pronounced seasonality, forecast conservatism, or an expectation of weaker pricing and/or cost conditions in the final quarter. The full-year dividend forecast of ¥39 per share implies a dividend payout ratio of approximately 31.9% based on forecast EPS of ¥122.08, which is conservative on an earnings basis.
Profitability Analysis
The annualized DuPont decomposition is net profit margin of 1.8% multiplied by asset turnover of 1.404x and financial leverage of 2.07x, resulting in annualized ROE of 5.2%. The principal constraint on ROE is the low net margin rather than asset utilization or leverage. Revenue increased 7.4% YoY, but gross profit increased only 1.9%, demonstrating that the largest adverse operating change was gross-margin compression. Gross margin fell to 8.1%, down approximately 43bp YoY, consistent with cost inflation, product-mix pressure, or incomplete pass-through of procurement costs. SG&A expenses rose 12.2% YoY to ¥12.50bn, faster than sales growth, further reducing operating leverage. As a result, operating income fell 21.3% and operating margin contracted approximately 72bp to 1.9%. The quality alert for low operating efficiency is warranted: the 1.9% EBIT margin is below the 5% concern threshold and leaves earnings sensitive to modest changes in gross margin or overhead. The low gross margin is also material, as an 8.1% margin provides limited buffer against supplier-price volatility or competitive price pressure. Financial leverage of 2.07x contributes to ROE, but does not compensate for weak underlying operating profitability. The 1.408 interest-burden ratio reflects non-operating income exceeding net interest costs, principally investment-related dividends and FX gains, rather than debt-funded financial strain. The tax burden was 0.663, equivalent to an effective tax rate of 33.7%, which was moderately higher than a normalized 30% level and reduced conversion of pre-tax profit into net income. Segment profitability confirms that the core Chemical Products business remained profitable but weakened, while the Civil Engineering and Construction Materials business moved into loss.
Growth Assessment
Revenue growth was led by the Chemical Products business, whose sales rose 9.1% YoY to ¥187.28bn and accounted for 92.4% of consolidated revenue. As the largest contributor to segment profit at ¥4.77bn, Chemical Products is the core business, although its segment profit declined 8.7% YoY and its segment margin compressed to 2.5% from 3.0%. Household Products sales declined 10.9% YoY to ¥5.81bn, while segment profit fell 38.5% to ¥0.48bn; its segment margin declined to 8.3% from 12.0%. Civil Engineering and Construction Materials sales fell 9.3% YoY to ¥9.70bn and shifted from a ¥0.19bn segment profit to a ¥0.03bn segment loss. Segment margins therefore remain meaningfully differentiated: Household Products has the highest margin despite deterioration, Chemical Products generates the majority of absolute profit on a low margin, and Civil Engineering and Construction Materials is currently loss-making. Corporate and unallocated expenses increased 6.1% to ¥1.31bn, further limiting conversion of segment profit into consolidated operating income. FY2026 full-year revenue guidance is ¥244.64bn, and Q3 cumulative revenue represents 82.9% progress, 7.9 percentage points ahead of the standard 75% pace. Operating-income progress is 96.7% against the ¥4.05bn forecast, 21.7 percentage points ahead of the standard pace. Ordinary-income progress is 92.6% against the ¥5.94bn forecast, while net-income progress is 87.6% against the ¥4.17bn forecast. The unusually high profit progress rates indicate limited implied Q4 earnings, with management apparently expecting operating conditions to become substantially more difficult or retaining a cautious forecast. Sustainable growth will depend on restoring gross-margin conversion in Chemical Products, stabilizing Household Products profitability, and returning the Civil Engineering and Construction Materials segment to profitability.
Financial Health
Liquidity is adequate, with current assets of ¥128.29bn against current liabilities of ¥83.52bn, producing a current ratio of 153.6%. The quick ratio of 146.3% is also healthy, indicating that liquidity is not dependent on inventory liquidation. Cash and deposits were ¥20.53bn, while inventories were modest at ¥6.09bn, equal to 3.2% of total assets. Debt-to-equity was 1.07x, above the conservative 1.0x benchmark but well below the 2.0x level that would indicate aggressive leverage; therefore, no high-leverage warning is triggered. Current liabilities are largely trade-related, including ¥70.80bn of accounts payable, rather than indicating a clear maturity mismatch against ¥128.29bn of current assets. Trade payables increased ¥20.69bn YoY, or 41.3%, to ¥70.80bn, materially exceeding the 17.8% increase in total assets. This increase helped finance the expansion in trade receivables and should be monitored for supplier-payment terms, purchasing volume, and working-capital normalization risk. Total trade and electronic receivables, including accounts receivable, notes receivable, and electronically recorded claims, were ¥100.79bn, representing a substantial working-capital commitment. The 103-day DSO quality alert is material because collection timing is a key determinant of liquidity and cash conversion in a distribution-oriented business. Investment securities totaled ¥57.46bn, or 29.8% of total assets, and accumulated other comprehensive income was ¥36.97bn, indicating that book equity is meaningfully influenced by unrealized securities valuation gains. Deferred tax liabilities were ¥15.12bn, largely consistent with the sizable securities valuation reserve. There was no reported goodwill impairment or segment-level impairment charge.
Notable B/S Changes
Accounts payable: +¥20.69bn (+41.3%) to ¥70.80bn - materially increased supplier financing supported working capital; monitor payment terms and potential cash requirement if balances normalize. Accounts receivable: +¥11.45bn (+17.7%) to ¥76.05bn - higher customer balances, together with 103-day DSO, increase collection and cash-conversion sensitivity. Electronically recorded monetary claims: +¥8.03bn (+65.5%) to ¥20.29bn - further expansion of receivable-related working capital reinforces the need to monitor collections. Total assets: +¥21.57bn (+12.6%) to ¥192.55bn - balance-sheet expansion was concentrated in current operating assets and receivables. Investment securities: +¥1.70bn (+3.1%) to ¥57.46bn - securities remain a substantial 29.8% of total assets and expose equity to market-value movements. Intangible assets: +¥0.03bn (+202.3%) to ¥0.04bn - percentage growth is high but the absolute amount is immaterial to the balance sheet.
Cash Flow Quality
Operating cash flow, investing cash flow, financing cash flow, free cash flow, capital expenditure, and OCF-to-net-income conversion are not assessed here. Working-capital quality nonetheless warrants close attention because DSO was 103 days, well above the 60-day alert threshold. Accounts receivable increased ¥11.45bn YoY to ¥76.05bn, and electronically recorded monetary claims increased ¥8.03bn to ¥20.29bn. This indicates that a significant portion of incremental revenue is tied up in customer balances. The increase in receivable-related balances was substantially accompanied by a ¥20.69bn increase in accounts payable, implying that supplier credit has been an important source of working-capital funding. Inventories were essentially flat YoY at ¥6.09bn, which reduces the risk that earnings growth is being supported by inventory accumulation. The central cash-conversion risk is therefore collections rather than inventory management. Dividend income of ¥0.95bn also supported reported profit, but is distinct from the operating earnings generated by the company’s trading activities.
Dividend Sustainability
The full-year dividend forecast is ¥39 per share. Based on forecast EPS of ¥122.08, the implied dividend-only payout ratio is approximately 31.9%. This is below the 60% sustainability benchmark and leaves a meaningful earnings retention buffer. Forecast net income of ¥4.17bn would cover estimated cash dividends of approximately ¥1.33bn based on 3.42 million average shares. The payout framework therefore appears conservative from an earnings perspective. Sustainability remains most sensitive to whether the company can protect its low 1.9% operating margin and convert receivables into cash on a timely basis. No share-buyback amount is provided, so a total return ratio is not calculated.
Risk Assessment
Business risks include Margin and pricing risk: Gross margin fell approximately 43bp to 8.1%, while operating margin fell approximately 72bp to 1.9%. In a low-margin chemical-product distribution model, incomplete pass-through of supplier cost inflation or competitive pricing pressure can have an outsized effect on profit., Chemical Products concentration: The core Chemical Products business accounts for 92.4% of revenue and generated ¥4.77bn of segment profit. Its 8.7% decline in segment profit despite 9.1% sales growth demonstrates weak incremental margin conversion., Segment turnaround risk: Civil Engineering and Construction Materials recorded a ¥0.03bn segment loss after a ¥0.19bn profit in the prior-year period, while sales declined 9.3%., Household Products deterioration: Sales fell 10.9% and segment profit fell 38.5%, with margin declining from 12.0% to 8.3%., Industry-specific working-capital risk: Distribution and trading businesses are exposed to counterparty credit, payment-term, and supplier-credit conditions. DSO of 103 days heightens the sensitivity of cash conversion to customer collections..
Financial risks include Receivables and collection risk: DSO of 103 days exceeds the 60-day quality-alert threshold. Receivable-related balances reached ¥100.79bn, making collection discipline material to liquidity., Payables normalization risk: Accounts payable increased 41.3% YoY to ¥70.80bn. A reversal in supplier financing or payment terms could require cash funding., Capital-efficiency risk: Annualized ROIC of 4.8% is below the 5% warning threshold, and annualized ROE of 5.2% remains below an 8% adequacy benchmark., Market-value exposure: Investment securities were ¥57.46bn, or 29.8% of total assets, while accumulated other comprehensive income was ¥36.97bn. Equity is consequently exposed to movements in securities valuations..
Key concerns include LOW_OPERATING_EFFICIENCY: EBIT margin of 1.9% is below 5%. The root cause is gross-margin compression combined with SG&A growth of 12.2%, above 7.4% revenue growth. The impact is elevated earnings volatility because a small decline in pricing or cost recovery can materially reduce profit., CAPITAL_EFFICIENCY: Annualized ROIC of 4.8% is below 5%. The low operating margin is the key driver, and the sizable investment-securities balance increases the capital base relative to operating earnings. The impact is that value creation and internal funding capacity remain constrained unless operating returns improve., HIGH_RECEIVABLE_DAYS: DSO of 103 days signals slow cash conversion. This is especially relevant for a trading/distribution business with substantial customer and supplier balances. The impact is greater dependence on trade payables and potential liquidity pressure if collections weaken., LOW_GROSS_MARGIN: Gross margin of 8.1% is below 20% and declined YoY. Although low gross margins can be structurally typical for distribution activities, the deterioration alongside profit decline is unfavorable. The impact is limited resilience against procurement-cost, foreign-exchange, and competitive-pricing movements., FY2026 guidance embeds a very low implied Q4 operating profit of approximately ¥0.14bn, despite Q3 cumulative operating income already reaching ¥3.91bn. This makes forecast execution and the reason for the implied final-quarter slowdown key issues..
Investment Implications
Key takeaways include Sales momentum is positive, with Q3 cumulative revenue up 7.4% YoY, but profitability conversion is negative: operating income fell 21.3%., Chemical Products remains the core earnings engine, but its segment margin fell to 2.5%, making gross-margin recovery the central operating issue., The company has sound short-term liquidity, supported by a 153.6% current ratio and 146.3% quick ratio., Receivable days of 103 and the 41.3% increase in accounts payable indicate that working-capital discipline is central to assessing earnings durability., The FY2026 dividend forecast implies a moderate 31.9% payout ratio based on forecast EPS, providing an earnings-based cushion., Large investment securities and related unrealized valuation reserves provide balance-sheet value exposure but can introduce equity volatility..
Metrics to watch include Gross margin and consolidated operating margin, Chemical Products segment margin and segment profit, Civil Engineering and Construction Materials segment return to profitability, DSO and receivable-related balance growth, Accounts-payable growth and supplier payment terms, Q4 operating profit relative to the ¥0.14bn implied by full-year guidance, Annualized ROIC and annualized ROE, Investment-securities valuation movements and accumulated other comprehensive income.
Regarding relative positioning, The company exhibits adequate liquidity and a conservative earnings payout ratio, but its profitability profile is weak for a trading/distribution business, with a 1.9% operating margin, 4.8% annualized ROIC, and 5.2% annualized ROE. Relative operating positioning will depend primarily on its ability to defend gross margins and improve collection efficiency rather than on revenue expansion alone.